General Information of Drug (ID: DM326CN)

Drug Name
Tyropanoate sodium
Synonyms
Sodium tyropanoate; Tyropanoate sodium; Lumopaque; Natrii tyropanoas; Natrium tyropanoat; Tyropaque; Bilopaque; Bilopac; Natrii tyropanoas [INN-Latin]; 7246-21-1; Tiropanoato sodico [INN-Spanish]; Tyropanoic acid sodium salt; Tyropanoate de sodium [INN-French]; EINECS 230-653-9; NSC-107434; Tyropanoate Sodium [USAN]; WIN 8851-2; Natrium 2-(3-butyramido-2,4,6-triiodbenzyl)butyrat; WIN-8851-2; Sodium 3-butyramido-alpha-ethyl-2,4,6-triiodohydrocinnamate; 2-(3-Butyramido-2,4,6-triiodbenzyl)buttersaeure, Natrium-Salz
Indication
Disease Entry ICD 11 Status REF
Gallbladder disease DC11.3 Approved [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C15H17I3NNaO3
Canonical SMILES
CCCC(=O)NC1=C(C=C(C(=C1I)CC(CC)C(=O)[O-])I)I.[Na+]
InChI
1S/C15H18I3NO3.Na/c1-3-5-12(20)19-14-11(17)7-10(16)9(13(14)18)6-8(4-2)15(21)22;/h7-8H,3-6H2,1-2H3,(H,19,20)(H,21,22);/q;+1/p-1
InChIKey
KTVKGXZZBQCBGD-UHFFFAOYSA-M
Cross-matching ID
PubChem CID
541384
ChEBI ID
CHEBI:32273
CAS Number
7246-21-1
TTD ID
D08EVN

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015